CRK vs LBRT

CRK presents a contradictory profile: explosive growth and strong profitability contrasted with severe liquidity risks. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the current ratio of 0.49 signals a critical short-term liquidity deficit. While the stock trades near its Graham Number ($17.05), the intrinsic value ($10.01) and a bearish technical trend (0/100) suggest the market is pricing in significant risk. The massive YoY EPS growth (+610.5%) is the primary bullish driver, but it is offset by insider selling and poor short-term price momentum.

LBRT exhibits a significant valuation disconnect, trading at $33.05 despite a Graham Number of $16.21 and an Intrinsic Value of $26.85. While the Piotroski F-Score of 4/9 indicates stable but mediocre financial health, the forward P/E of 93.50 suggests a looming earnings contraction or extreme overpricing. Despite a massive 1-year price surge of 175.5%, the underlying fundamentals—specifically a low operating margin of 0.37% and revenue growth lagging far behind the sector average—do not support current levels. Bearish insider activity at 52-week highs further signals a lack of confidence in further upside.